AR and prostate cancer: As for PMEPA1, some studies have shown PMEAP1 inhibited proliferation through androgen receptor,11 however, androgen receptor and the related signalling pathways have been activated in prostate cancer, but maybe not in lung cancer or breast, or colorectal cancer.